CBI-1214 A Phase 1 bispecific T-cell engager engineered for anti-tumor activity across MSS and MSI-low colorectal cancer.
Visit productCosigns Received
Be the first Cosign
Put your name behind CBI-1214.
Add it to your Products I use list and share why you use it.